Site notifications

Sub menu

 
 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

1073 result(s) found, displaying 1051 to 1073

  • AusPAR: Tacrolimus

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Tacrolimus

  • AusPAR: Fibrin sealant

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Fibrin sealant

  • AusPAR: Ropivacaine

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ropivacaine

  • AusPAR: Telmisartan

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Telmisartan

  • AusPAR: Abatacept (rch)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Abatecept (rch)

  • AusPAR: Vildagliptin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Vildagliptin

  • AusPAR: Bevacizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Bevacizumab

  • AusPAR: Aztreonam

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Aztreonam

  • AusPAR: Miglustat

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Miglustat

  • AusPAR: Somatropin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Somatropin

  • AusPAR: Cetuximab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Cetuximab

  • AusPAR: Rituximab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Rituximab

  • AusPAR: Certolizumab pegol

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Certolizumab pegol

  • AusPAR: Ziprasidone mesilate

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ziprasidone mesilate

  • AusPAR: Golimumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Golimumab

Help us improve this page